DPNI-caged-GABA |
Catalog No.GC14150 |
activates GABAA receptor
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 927866-58-8
Sample solution is provided at 25 µL, 10mM.
IC50: N/A
DPNI-GABA, also known as Nitroindoline-caged GABA, has similar photochemical properties with MNI-glutamate, including the same quantum yield (0.085), highly water soluble, exhibitting fast photorelease that is efficient at near-UV and 405 nm wavelengths.
In vitro: Under the condition of retaining the advantages of nitroindoline cages, DPNI-GABA were modified to minimize the pharmacological interference commonly found with caged GABA reagents. Unlike previous test of the 5-methoxycarbonylmethyl-7-nitroindolinyl-GABA, DPNI-GABA reduced peak GABA-evoked responses with an IC50 of approximately 0.5mM, and blocked GABAA receptors with much lower affinity,. It is most important that the kinetics of receptor activation, comparable to synaptic events, were determined as 10–90% rise-times, and had no effect by DPNI-GABA present at 1 mM concentration, and permitted photolysis of DPNI-GABA to mimic synaptic activation of GABAA receptors. As estimated, the spatial resolution of uncaging DPNI-GABA in dendrites was 2m laterally and 7.5m focally with a laser spot of 1mapplied to cerebellar molecular layer interneurons. Finally, photorelease restricted to the area of the soma inhibited spiking in single Purkinje neurons or molecular layer interneurons for periods regulated by the flash intensity and duration at low DPNI-GABA concentration [1,2].
Under resting conditions, miniature synaptic currents have long been known to represent random transmitter release, but their nature and function in central synapses much remains to be learned about. A new class of miniature currents (‘‘preminis’’) arise by the autocrine activation of axonal receptors following random vesicular release. During the development of the molecular layer, preminis are prominent in gabaergic synapses made by cerebellar interneurons. Premini frequencies, unlike ordinary miniature postsynaptic currents in the same cells, are strongly enhanced by subthreshold depolarization, suggesting that themembrane depolarization they produce belongs to a feedback loop controlling neurotransmitter release. Thus, preminis enhanced neurotransmitter release to guide the formation of the interneuron network at recently formed synaptic contacts [3].
In vivo: So far, no study in vivo has been conducted
Clinical trial: So far, no clinical study has been conducted.
References:
[1]. Wieboldt R, Ramesh D, Carpenter BK, Hess GP. Synthesis and photochemistry of photolabile derivatives of gamma-aminobutyric acid for chemical kinetic investigations of the gamma-aminobutyric acid receptor in the millisecond time region. Biochemistry. 1994 Feb 15;33(6):1526-33.
[2]. Trigo FF, Papageorgiou G, Corrie JE, Ogden D. Laser photolysis of DPNI-GABA, a tool for investigating the properties and distribution of GABA receptors and for silencing neurons in situ. J Neurosci Methods. 2009 Jul 30;181(2):159-69. doi: 10.1016/j.jneumeth.2009.04.022. Epub 2009 May 5.
[3]. Trigo FF, Bouhours B, Rostaing P, Papageorgiou G, Corrie JE, Triller A, Ogden D, Marty A. Presynaptic miniature GABAergic currents in developing interneurons. Neuron. 2010 Apr 29;66(2):235-47.
Cas No. | 927866-58-8 | SDF | |
Chemical Name | 2-((1-(4-aminobutanoyl)-7-nitroindolin-4-yl)oxy)propane-1,3-diyl bis(dihydrogen phosphate) | ||
Canonical SMILES | NCCCC(N1CCC2=C(OC(COP(O)(O)=O)COP(O)(O)=O)C=CC(N(=O)=O)=C21)=O | ||
Formula | C15H23N3O12P2 | M.Wt | 499.3 |
Solubility | <1mg/ml in Water | Storage | Store at -20°C |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Prepare stock solution | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 2.0028 mL | 10.014 mL | 20.028 mL |
5 mM | 0.4006 mL | 2.0028 mL | 4.0056 mL |
10 mM | 0.2003 mL | 1.0014 mL | 2.0028 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5
(Based on Reviews and 16 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *